Claire M Gulmi

CIK 1200152 · CFO · last filed 2026-05-26

Claire M Gulmi is a CFO who has filed 63 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $132.0K of CHCT on May 26, 2026. Across all open-market trades the lifetime net is −$17.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $947.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$947.0K

Companies

Total Filings

Lifetime Open-Market Net

-$17.16M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

AMSG price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CHCT	Director	71,523	$13.24	$947.0K	$172.1K	18	2026-05-26
Envision Healthcare Corp (EVHC) Delisted	CFO	119,772	—	—	$0	5	2017-03-06
AMSURG CORP (AMSGP) Delisted	Executive VP & CFO	0	—	—	$0	1	2016-12-01
AMSURG CORP (AMSG.P) Delisted	Executive VP & CFO	116,848	—	—	-$2.81M	7	2016-02-26
AMSURG CORP (AMSG) Delisted	Executive VP & CFO	113,896	—	—	-$14.53M	29	2014-02-04

Recent Filings

63 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-05-26	CHCT	Grant (A)	+7,661	$132.0K	EDGAR
2026-05-08	CHCT	Grant (A)	+6,222	$0	EDGAR
2025-05-16	CHCT	Grant (A)	+7,933	$132.0K	EDGAR
2025-05-02	CHCT	Grant (A)	+6,524	$0	EDGAR
2024-05-17	CHCT	Grant (A)	+5,439	$132.0K	EDGAR
2024-05-06	CHCT	Grant (A)	+4,414	$0	EDGAR
2023-05-19	CHCT	Grant (A)	+3,046	$108.0K	EDGAR
2023-05-08	CHCT	Grant (A)	+2,751	$0	EDGAR
2023-03-13	CHCT	Buy (P)	+2,042	$75.1K	EDGAR
2022-05-23	CHCT	Grant (A)	+2,949	$108.0K	EDGAR

Showing 1–10 of 63

Page 1 of 7 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.